TY  - JOUR
AU  - Torrente-Lopez, Anabel
AU  - Hermosilla, Jesus
AU  - Salmeron-Garcia, Antonio
AU  - Cabeza, Jose
AU  - Navas, Natalia
PY  - 2022
DO  - 10.3390/pharmaceutics14040692
SN  - 1999-4923
UR  - http://hdl.handle.net/10668/21547
T2  - Pharmaceutics
AB  - Nivolumab, formulated in the medicine Opdivo® (10 mg/mL), is a therapeutic monoclonal antibody (mAb) used in the treatment of different types of cancer. Currently, there is insufficient knowledge about the behaviour of this protein with regards to the...
LA  - en
PB  - MDPI AG
KW  - UHPLC-MS
KW  - comprehensive analytical characterisation
KW  - forced degradation
KW  - isoform profile
KW  - nivolumab
KW  - Nivolumab
KW  - Antibodies, Monoclonal
KW  - Sodium Chloride
KW  - Chromatography, High Pressure Liquid
KW  - Exercise Test
KW  - Neoplasms
KW  - Protein Isoforms
KW  - Enzyme-Linked Immunosorbent Assay
KW  - Hospitals
TI  - Comprehensive Analysis of Nivolumab, A Therapeutic Anti-Pd-1 Monoclonal Antibody: Impact of Handling and Stress.
TY  - research article
VL  - 14
ER  -